Activated protein C reduces graft neutrophil activation in clinical renal transplantation

American Journal of Transplantation

Volumn 5, Issue 9, 2005, Pages 2204-2212

  Turunen, Arto J ^a,e   Fernández, José A ^d   Lindgren, Leena ^b   Salmela, Kaija T ^a   Kyllönen, Lauri E ^a   Mäkisalo, Heikki ^a   Griffin, John H ^d   Siitonen, Sanna M ^a   Petäjä, Jari ^a,c   Pesonen, Eero J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c JORVI HOSPITAL   (Finland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e KANTA HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Activated protein; ATG; Inflammation; Ischemia reperfusion; Renal transplantation

Indexed keywords

ACTIVATED PROTEIN C; AZATHIOPRINE; BASILIXIMAB; CD11B ANTIGEN; CYCLOSPORIN; L SELECTIN; LACTOFERRIN; STEROID; THYMOCYTE ANTIBODY;

ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; GRAFT INFECTION; HUMAN; ILIAC ARTERY; ISCHEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE ACTIVATION; LEUKOCYTE DIFFERENTIAL COUNT; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTIGENS, CD11B; ANTILYMPHOCYTE SERUM; HUMANS; KIDNEY TRANSPLANTATION; L-SELECTIN; LACTOFERRIN; LEUKOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; ORGAN PRESERVATION; PHAGOCYTES; PROTEIN C; RECOMBINANT FUSION PROTEINS; REPERFUSION; REPERFUSION INJURY; THYMUS GLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 27844463615     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00994.x     Document Type: Article

References (30)

1. Esmon CT, Taylor FB Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160-165.
2. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-925.
3. Bernard GR, Vincent JL, Laterre PF et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
4. Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003; 1: 1343-1348.
5. Thiagarajan RR, Winn RK, Harlan JM. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost 1997; 78: 310-314.
6. Mackman N. The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury. Semin Vasc Med 2003; 3: 193-198.
7. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781-3787.
8. Petaja J, Pesonen E, Fernandez JA et al. Activated protein C and inflammation in human myocardium after heart surgery. Am J Hematol 2001; 67: 210-212.
9. Ilmakunnas M, Petaja J, Hockerstedt K et al. Activation of protein C during reperfusion in clinical liver transplantation. Transplantation 2003; 75: 467-472.
10. Cheng T, Liu D, Griffin JH et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 2003; 9: 338-342.
11. Turunen AJ, Lindgren L, Salmela KT et al. Association of graft neutrophil sequestration with delayed graft function in clinical renal transplantation. Transplantation 2004; 77: 1821-1826.
12. Salmela K, Kyllonen L, Eklund B et al. Thirty years of renal transplantation in Helsinki. In: Terasaki PI, Cecka JM, eds. Clinical transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1994: 219-228.
13. Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood 1992; 79: 2340-2348.
14. Repo H, Jansson SE, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993; 164: 193-202.
15. Repo H, Jansson SE, Leirisalo-Repo M. Anticoagulant selection influences flow cytometric determination of CD11b upregulation in vivo and ex vivo. J Immunol Methods 1995; 185: 65-79.
16. Pesonen EJ, Linder N, Raivio KO et al. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 1998; 114: 1009-1015.
17. Halloran PF, Aprile MA, Farewell V et al. Early function as the principle correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating anti-lymphocyte globulin and cyclosporine. Transplantation 1988; 46: 223-228.
18. van Eeden S, Miyagashima R, Haley L, Hogg JC. L-selectin expression increases on peripheral blood polymorphonuclear leukocytes during active marrow release. Am J Respir Crit Care Med 1995; 151: 500-507.
19. Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ. Expression and function of the endothelial protein C receptor in human neutrophils. Blood 2003; 102: 1499-1505.
20. Grinnell BW, Hermann RB, Yan SB. Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 1994; 4: 221-225.
21. Shibata M, Kumar SR, Amar A et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 2001; 103: 1799-1805.
22. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 1994; 153: 3664-3672.
23. White B, Schmidt M, Murphy C et al. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol 2000; 110: 130-134.
24. Kyllonen LE, Salmela KT, Eklund BH et al. Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int 2000; 13: 122-128.
25. Faust SN, Levin M, Harrison OB et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001; 345: 408-416.
26. Kyllönen L, Eklund B, Matinlauri I, Salmela K. Induction with single bolus ATG or basiliximab in cadaveric kidney transplantation with cyclosporine immunosuppression [Abstract]. Transplantation 2002; 74: 466.
27. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986; 251: H314-H323.
28. Yokota N, Daniels F, Crosson J, Rabb H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 2002; 74: 759-763.
29. Goggins WC, Pascual MA, Powelson JA et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798-802.
30. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, Revillard JP. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003; 75: 657-662.